Phaos Technology Holdings (Cayman) (POAS) Debt Ratio (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) reported Debt Ratio of 0.08 for Q4 2025, up 20.28% quarter-over-quarter from 0.07 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Debt Ratio (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) has reported Debt Ratio for 2 years, with the latest figure at 0.08 in Q4 2025.

For the quarter ending Q4 2025, Debt Ratio changed N/A year-over-year to 0.08; the trailing twelve-month figure through Oct 2025 stood at 0.08 (changed N/A YoY), and the FY2025 full-year result was 0.07, down 37.48% from the prior year.
Debt Ratio for Q4 2025 stood at 0.08, up from 0.07 in the prior quarter.
The five-year high for Debt Ratio was 0.11 in Q2 2024, with the low at 0.07 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.31
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.32
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.31
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.30
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.27
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.18
10	Phaos Technology Holdings (Cayman)	682,234.12	627,245.12	-	0.08

Download Data